Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
SLAS Discovery : Advancing Life Sciences R & D|August 16, 2024
Development of a sensitive high-throughput enzymatic assay capable of measuring sub-nanomolar inhibitors of SARS-CoV2 MproPeter Kovar, Paul L Richardson, Alla Korepanova, et al.Analytical Biochemistry|September 27, 2003
A cell-based microarrayed compound screening format for identifying agonists of G-protein-coupled receptorsSujatha M Gopalakrishnan, Robert B Moreland, James L Kofron, et al.Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1Ramin Faghih, Wesley Dwight, Robert Gentles, et al.Journal of Medicinal Chemistry|August 8, 2008
The alkaloid conessine and analogues as potent histamine H3 receptor antagonistsChen Zhao, Minghua Sun, Youssef L Bennani, et al.Journal of Medicinal Chemistry|May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptorRamin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.Journal of Medicinal Chemistry|July 14, 2018
Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315Clarissa G Jakob, Anup K Upadhyay, Pamela L Donner, et al.ACS Chemical Biology|February 21, 2022
The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for ImmunotherapySven Malchow, Alla Korepanova, Sanjay C Panchal, et al.Scientific Reports|August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal siteEric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.Journal of Medicinal Chemistry|September 25, 2008
Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligandsRobert J Altenbach, Ronald M Adair, Brian M Bettencourt, et al.Scientific Reports|June 26, 2019
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque PsoriasisViktor Todorović, Zhi Su, C Brent Putman, et al.Pageof 4